ロード中...
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas(†)
The objective of this study was to evaluate whether longitudinal levels of serum YKL-40 correlate with disease status or survival in adults with gliomas. Patients with histologically confirmed gliomas were eligible for this longitudinal study. Serum samples were collected prospectively and concurren...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3199155/ https://ncbi.nlm.nih.gov/pubmed/21831900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor117 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|